Abvc Biopharma (ABVC) Total Debt (2009 - 2026)
Abvc Biopharma (ABVC) recorded Total Debt of $240 billion in Q3 2026, up 60.0% from $150 billion a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Total Debt (2009 - 2026) Analysis & Trends
Starting with Q2 2009, Abvc Biopharma's Total Debt history includes 53 quarters.
- Annual Total Debt has a five-year compound annual growth rate of 952.3% (FY2020 to FY2025).
- Across earlier years, Total Debt came in at $840,252 in FY2024 (-42.8%), $1.47 million in FY2023 (-22.4%), $1.89 million in FY2022 (+15.5%) and $1.64 million in FY2021 (-11.8%).
- Quarterly Total Debt has ranged from $801,407 in Q1 2025 to $240 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Total Debt rose in 1 of the last four quarters, with an average decline of 11.2%.
- Peak year-over-year performance for Total Debt in the last five years was growth of 88.8% in Q1 2024, against a decline of 54.3% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $240 billion (Q2 2026), $240 billion (Q1 2026) and $240 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 49.50 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 80.90 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 53.78 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -6.68 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 54.01 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 26.23 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 62.67 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 240.00 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 240.00 Bn |
| Jun 30, 2026 | 240.00 Bn |
| Mar 31, 2026 | 240.00 Bn |
| Dec 31, 2025 | 240.00 Bn |
| Sep 30, 2025 | 150.00 Bn |
| Jun 30, 2025 | 871,951.00 |
| Mar 31, 2025 | 801,407.00 |
| Dec 31, 2024 | 840,252.00 |
| Sep 30, 2024 | 896,250.00 |
| Jun 30, 2024 | 956,880.00 |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 852,500.00 |
| Jun 30, 2023 | 882,750.00 |
| Mar 31, 2023 | 902,000.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.64 Mn |
API Access
Abvc Biopharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();